Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: a six-month trial
Casson P, Santoro N, Elkind-Hirsch K, Carson S, Hornsby P, Abraham G, Buster J. Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: a six-month trial. Fertility And Sterility 1998, 70: 107-110. PMID: 9660430, DOI: 10.1016/s0015-0282(98)00121-6.Peer-Reviewed Original ResearchMeSH KeywordsAndrogensBody CompositionDehydroepiandrosteroneDouble-Blind MethodFemaleHumansInsulin-Like Growth Factor Binding Protein 3Insulin-Like Growth Factor ILipoproteins, HDLMiddle AgedPostmenopauseTime FactorsConceptsHigh-density lipoproteinInsulin-like growth factorLevels of DHEADHEA therapySerum DHEAImmune indicesFree insulin-like growth factorDual-energy X-ray absorptiometry scanX-ray absorptiometry scansA1 levelsGrowth factorLiver function testsInsulin-sensitizing propertiesRatio of IGFSmall study sizeSix-month trialPostdose levelsPremenopausal rangePostmenopausal womenIGFBP-3Function testsInsulin sensitivityReferral practicesParallel trialMAIN OUTCOME